logo-loader
viewCambian Group

Cambian agrees to be taken over by CareTech for up to £372mln

Analysts at Liberum believe the value of Cambian is "meaningfully greater" than what CareTech has offered for the firm but they see the benefits of the proposed merger

children
CareTech is looking to expand its childcare business

Cambian Group PLC, a provider of education and behavioural health services for children, has agreed to be taken over by CareTech Holdings PLC (LON:CTH) in a deal that could be valued up to £372mln.

CareTech, which offers social care services, has been in talks with Cambian since July as it seeks to expand its child care business.

It is offering cash-and-stock or all cash for Cambian. The cash and stock deal includes 0.267 new shares and 100p in cash for each Cambian share held, representing a total value of 200p per share or £372mln.

Under the all-cash offer, CareTech will pay 190p for each Cambian share. Cambian’s closing share price on Wednesday was 190.5p, which values the group at £353mln. 

Bid lower than first offer

The latest proposals are below CareTech’s first bid in July, which was 220p per share in cash and stock or 200p per share in full cash.

READ: Cambian jumps after around £405mln takeover proposal from social care services rival CareTech

CareTech said it expects the deal to create pre-tax cost synergies of about £6mln per year by 2021.

“The financial rationale for the Transaction is compelling in its potential to generate value for both CareTech shareholders and Cambian shareholders,” said CareTech chairman Farouq Sheikh.

“At the same time, the larger size of the enlarged group means that more funds will be made available to the CareTech Charitable Foundation to accelerate its important work in giving back to the most disadvantaged communities.”

Shares in Cambian rose 1.8% to 194p in mid-morning trading while CareTech edged up 0.7% to 377p.

Liberum sees benefits of enlarged group but downgrades Cambian 

Liberum downgraded Cambian to a 'hold' rating from 'buy' and cut its target price to 200p from 238p.

“In sum, while we clearly believe the value of Cambian is meaningfully greater (previous target price £2.38) than that agreed today, we expect this deal to be completed (subjected to competition authority approval) and can see the attractions of the new combined entity,” said Liberum.

Quick facts: Cambian Group

Price: - -

LSE:CMBN
Market: LSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: BioCorRx says COVID-19 will not delay their work on...

BioCorRx (OTCMKTS: BICX) CEO Brady Granier joined Steve Darling from Proactive in Vancouver to discuss if their business and research are being affected by the outbreak of COVID-19. Granier telling Proactive some of the ways the company is able to continue their works especially when it...

13 hours, 43 minutes ago

2 min read